The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model

被引：0
|
作者：
Mateja Erdani Kreft
Urška Dragin Jerman
Eva Lasič
Tea Lanišnik Rižner
Neli Hevir-Kene
Luka Peternel
Katja Kristan
机构：
[1] University of Ljubljana,Institute of Cell Biology, Faculty of Medicine
[2] Lek Pharmaceuticals,Institute of Biochemistry, Faculty of Medicine
[3] d.d.,undefined
[4] Sandoz Development Center Slovenia,undefined
[5] University of Ljubljana,undefined
来源：
Pharmaceutical Research | 2015年 / 32卷
关键词：
drug transporters; microscopy; nasal epithelial cell model; permeability; TEER;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：665 / 679
页数：14
相关论文
共 50 条
  • [1] The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model
    Kreft, Mateja Erdani
    Jerman, Urska Dragin
    Lasic, Eva
    Rizner, Tea Lanisnik
    Hevir-Kene, Neli
    Peternel, Luka
    Kristan, Katja
    PHARMACEUTICAL RESEARCH, 2015, 32 (02) : 665 - 679
  • [2] Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells
    Horvath, Tamas
    Bartos, Csilla
    Bocsik, Alexandra
    Kiss, Lorand
    Veszelka, Szilvia
    Deli, Maria A.
    Ujhelyi, Gabriella
    Szabo-Revesz, Piroska
    Ambrus, Rita
    MOLECULES, 2016, 21 (05)
  • [3] Cultivation of RPMI 2650 cells as an in-vitro model for human transmucosal nasal drug absorption studies: optimization of selected culture conditions
    Reichl, Stephan
    Becker, Karin
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (11) : 1621 - 1630
  • [4] RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies
    Wengst, Annette
    Reichl, Stephan
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 74 (02) : 290 - 297
  • [5] Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?
    Clément Mercier
    Nathalie Perek
    Xavier Delavenne
    European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 13 - 24
  • [6] Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?
    Mercier, Clement
    Perek, Nathalie
    Delavenne, Xavier
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (01) : 13 - 24
  • [7] Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650
    Ladel, Simone
    Schlossbauer, Patrick
    Flamm, Johannes
    Luksch, Harald
    Mizaikoff, Boris
    Schindowski, Katharina
    PHARMACEUTICS, 2019, 11 (08)
  • [8] Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability
    Levente Kürti
    Szilvia Veszelka
    Alexandra Bocsik
    Béla Ózsvári
    László G. Puskás
    Ágnes Kittel
    Piroska Szabó-Révész
    Mária A. Deli
    Cytotechnology, 2013, 65 : 395 - 406
  • [9] Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability
    Kuerti, Levente
    Veszelka, Szilvia
    Bocsik, Alexandra
    Ozsvari, Bela
    Puskas, Laszlo G.
    Kittel, Agnes
    Szabo-Revesz, Piroska
    Deli, Maria A.
    CYTOTECHNOLOGY, 2013, 65 (03) : 395 - 406
  • [10] The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-β gene expression and protein release
    Salib, RJ
    Lau, LC
    Howarth, PH
    CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (06): : 811 - 819
12345